• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Korea·Consumer Cyclical·192820.KS
Share

Cosmax, Inc. Stocks

₩ 187050Last Updated 28.07.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

₩ 1.40B

₩ 187050
Key Takeaways

Risk factor

Good trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Somewhat favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Cosmax, Inc. operates as a global entity engaged in the research, development, manufacturing, and distribution of a broad spectrum of goods, including cosmetic items, nutritional supplements, and pharmaceutical products. Its comprehensive beauty product line features skincare formulations, decorative makeup, hair care essentials, and specialty treatments such as facial masks and under-eye patches. Beyond its cosmetic offerings, the company also develops and produces medical equipment and supplies, provides raw materials for cosmetic formulations, and manufactures advanced containers and filling packaging for cosmetics. Originally established as Miroto Korea, the company rebranded to Cosmax, Inc. in 1994. Founded in 1992, its primary corporate offices are located in Hwaseong, South Korea.

Company Valuation

Slightly overvalued
3/7

From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral on E

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of 192820.KS is 249270 and suggests 39.7% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

28.07.2026 16:24

Iran and Oman are negotiating the reopening of the Strait of Hormuz. Brent crude is down 2%.

28.07.2026 15:39

Morning in New York: Investors Need New Signals

28.07.2026 15:12

Shares of a small-cap company developing a treatment for vitiligo have skyrocketed. A competitor wants to buy it.

28.07.2026 13:47

An Nvidia employee was detained in Taiwan in connection with a case involving the smuggling of AI chips to China

28.07.2026 12:29

Samsung and SK Hynix Plummeted Ahead of Earnings Reports: News from China Fueled Investor Fears

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026